Chicamann
$ENSC By not releasing the results to the Phase 3 trials we just have to assume that the results of your medication showed that it stunts chronic pain by killing its patient with cancer. The only reason I bought this stock was because someone who knew Lynn took the time to tell me great things about her and her company. I wish they had instead taken that time to simply stab me as many times as they possibly could. I would be in a better position in that case than I am holding shares of ENSC.
8
